To examine if LXR/RXR agonist treatment can alleviate amyloid plaque pathology in APP/E3/Abca1+/- and APP/E4/Abca1+/- mice, brain sections were stained with X-34 to visualize compact fibrillary amyloid plaques. The gene discussed is APP; the disease is amyloidosis.